EDITOR: | July 29th, 2015 | 2 Comments

Russian scientists plans to present the world’s first artificial human kidney and thyroid gland by 2018

| July 29, 2015 | 2 Comments

Vladimir Mironov and his bioprinter3D Bioprinting Solutions, one of Russia’s leading biotechnological laboratories, has officially announced the design of the world’s first organ construct of thyroid gland, which took place with use of FABION, Russia’s first bioprinter.

According to Vladimir Mironov, head of the laboratory, the new construct is comprised of several types of tissue and has its own vascularization. He has also added that the new development is designed for the implantation to test animals, however by 2018 scientists hope to complete the design of its analogue, that will be suitable for human transplantation.

The new technology was developed by scientists of  3D Bioprinting Solutions and is considered as one of the alternatives to stem cells. According to scientists, its use should help to solve a problem of a shortage of donor organs for transplantation in due course.

According to Vladimir Mironov,  the new technology is  produced by a new bioprinter, which is a robotic device, that allows to accurately allocate biomaterial, including living cells in layers in three-dimensional space. It was jointly designed by Russian scientists and scientists from the University of Vienna.

Mironov has also added that the new technology is based on the use of tissue spheroids (which are produced on the basis of microfluidics technology) as building blocks.

According to scientists of 3D Bioprinting Solutions, at present there are about 12 commercial bioprinters available globally, however the Russian model is probably the world’s most currently advanced, which is mainly due to its multifunctionality.

As part of the plans of 3D Bioprinting Solutions, is the production of human kidney, the most demanded organ for transplantation by 2018.

Scientists of the laboratory believe that they will be able to complete kidney design already during the next three years, despite the predictions of some Western scientists, according to which the production of the world’s first human kidney on the basis of bioprinter will take place no sooner than by 2030.

In the meantime, Russia’s leading doctors and scientists in the field of medicine believe that the technology will be suitable for the use in clinical practice.

According to Andrey Polyakov, head of department of neck tumors and microsurgery of the Moscow Medical Radiological Research Center, the produced artificial thyroid gland has its own vessels, both arterial and venous, which can provide blood flow and nutrition, as well as transportation of produced hormones for the body.

This is not the first successful development of Russian scientists in the field of tissue engineering, in 2013, in accordance with an initiative of Peter Glybochko, head of I.M. Sechenov First Moscow State Medical University, (Russia’s oldest and the largest national medical higher educational institution), a group of the university’s scientists had successfully created and transplanted a fragment of bioengineering urethra to a patient suffered from ankylurethria.

Eugene Gerden


Eugene Gerden is an international free-lance writer, based in St. Petersburg, who specializes on writing in the field of mining, metals and rare earth metals. ... <Read more about Eugene Gerden>

Copyright © 2019 InvestorIntel Corp. All rights reserved. More & Disclaimer »


  • Jack Lifton

    This is a wonderful attempt to solve a problem, the need for replacement organs, or at least for their functionality, synthetically. It goes hand-in-hand with the attempts to grow the individual organs outside of the body. I think the barrier to success is the current state of knowledge of the construction of these organs. We humans can only crudely mimic nature’s holistic systems that grow entire organisms simultaneously by trying to figure out how the “engineering” of the human body works and then trying to duplicate that using the “organic” processes of which we are aware. This very worthwhile project will require funding and the dedication of researchers to solving a problem rather than getting rich doing it. Solving problems to do good is not a specialty either of Russia or of capitalism or, for that matter, of America. I am going to keep a close watch on this project as I am watching the reports of low cost cancer vaccines developed in Cuba. Maybe, just maybe, the finanancialization of capitalism can be reduced and the utility of capitalism restored.

    July 29, 2015 - 1:00 PM

  • Paula

    greetings to my love

    July 30, 2015 - 7:01 AM

Leave a Reply

Your email address will not be published. Required fields are marked *